- Global Pharma News & Resources

Zika Virus Testing Market is expected to reach US$ 6.8 million by 2033, at a CAGR of 3.4%

According to FMI, the Zika Virus Testing Market size would likely increase from US$ 4.9 million in 2023 to US$ 6.8 million by 2033. The market is anticipated to see a CAGR of 3.4% throughout the course of this projection period.

The rising frequency of Zika virus infection is a major factor driving the rising need for Zika virus testing throughout the forecast period. Additionally, increased public awareness of the disease and the advantages of early diagnosis also contributes to the revenue growth. Besides, rising expenditures in R&D activities to develop novel tests and viral detection kits is also backing to the market growth.

Get a PDF Sample with Latest Market Insights@

Government efforts to promote awareness about the infection and its repercussions is positively influencing the market. They are also supporting the innovation of novel tests that can identify the Zika virus accurately.

The virus has impacted infants severely. ZIKV in pregnancy has been linked to infants who seem to have extreme microcephaly. Hence, the market for Zika virus testing has been expanding due to the necessity for a precise and prompt diagnosis.

To lessen the risk, nations are improving their testing infrastructure for mosquito-borne risks to public health. This is anticipated to have a positive effect on the Zika virus testing market’s growth trends. In the post-Covid era, research on diseases that might start pandemics is receiving increasingly more attention.

Advances in research of the biology of the clinical disorders linked to the virus has caused Zika virus testing encroachments. Phylogenetic analyses of several genomes have provided more insight in this area. In the upcoming years, market expansion is anticipated to be driven by technological developments in viral testing techniques.

The North American market dominated the industry in 2022 and is anticipated to grow at a significant CAGR over the forecast period. The most important element is the extensive development of cutting-edge testing methodologies. Besides, the stringent legislation requiring NAAT screening for Zika virus for every blood donor also supports the market growth.

However, due to the widespread incidence of the disorders in the region, the market in Latin America is anticipated to see a substantial growth rate. Government campaigns to raise awareness of the condition and growing knowledge of the available testing facilities are also drive market expansion.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you@


  • Over the forecast period, the Zika virus testing market in the United States is predicted to grow at a CAGR of 2.6%.
  • The CAGR for the United Kingdom Zika virus testing market is predicted to be 2.0% throughout the projection period.
  • The market for Zika virus testing in Mexico is anticipated to have a CAGR of 2.2% during the projected period.
  • The Zika virus testing market in Thailand is expected to grow at a CAGR of 2.4% over the forecast period.
  • With a CAGR of 3.4% throughout the assessment period, the market for Zika virus testing in Columbia is anticipated to increase speedily.
  • The ELISA kits category of the Zika virus testing market’s test type segment is predicted to develop at a CAGR of 3.2% through 2033.
  • In the market for Zika virus testing, the hospital and clinic section of the end-user category is estimated to showcase a CAGR of 3.0% over the forecast period.


Key companies in the Zika virus market are EUROIMMUN US Inc., Creative Diagnostics, Quest Diagnostics, Artron Laboratories Inc., RapiGEN Inc., GenBody Inc., JAJ International Inc., LumiQuick Diagnostics Inc., Biocan Diagnostics Inc., NECTAR LIFESCIENCES LTD., Luminex Corporation, ARUP Laboratories, Abbott Molecular Inc., Hologic, Vela Diagnostics and othes.

To enhance market, share and global presence, most of these businesses have committed in implementing a variety of market tactics, including merger and acquisition, cooperation, partnerships, product release, R&D activities, and capacity development.


The University of So Paulo in Brazil and Luminex have teamed together to verify a multi-analyte Zika virus test created by GenArraytion. A qualitative nucleic acid test called the MultiFLEX Mosquito-borne Panel is presently offered. It is provided as a multiplex panel for research use only (RUO). It may be used to identify a variety of disease agents, including the Zika virus.

Quest Diagnostics claimed that the FDA’s Emergency Use Authorization (EUA) has been granted for the Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test). The test was created by Focus Diagnostics, Inc., a subsidiary of Quest. Its reference laboratory division. The specialised molecular test is designed for the qualitative identification of Zika virus RNA in human serum samples from particular people.

For in-depth competitive analysis, Buy Now@

Key Segments Covered

Test Type:

  • Rapid IgG/IgM Test
  • ELISA Test


  • Hospitals & Clinics
  • Private Commercial Laboratories
  • Government/Publicly Funded Programs

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 20-Apr-2023